Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology — Massimo Filippi (1999) | RDL Network
The effect of 44 microgram rh-IFN beta-1a in reducing multiple sclerosis disease activity, as monitored by Gd enhanced MRI, is not homogeneous, but graduated according to the pathological characteristics and size of the lesions.
P. D. Molyneux, Ludwig Kappos, Chris H. Polman, Carlo Pozzilli, Frederik Barkhof, Massimo Filippi, Tarek Yousry, David W. Hahn, Klaus Wagner, Mahdiyeh Khabbaz Koche Ghazi, K. Beckmann, Frank Dahlke, Nicholas Losseff, Gareth J. Barker, Alan J. Thompson, D. H. Miller
Carlo Avolio, Massimo Filippi, Carla Tortorella, Maria A. Rocca, Maddalena Ruggieri, Federica Agosta, Valentina Tomassini, Carlo Pozzilli, S. Stecchi, Patrizia Giaquinto, Paolo Livrea, María Trojano
Discussion(0)
No comments yet. Be the first to comment.